Related references
Note: Only part of the references are listed.Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project
Fiona H. Blackhall et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Worse Disease-Free Survival in Never-Smokers with ALK plus Lung Adenocarcinoma
Ping Yang et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Share Paper
